Literature DB >> 310464

Mode of action of levamisole.

G Goldstein.   

Abstract

Levamisole is a heterocyclic compound that is an effective antihelminthic agent and is also immunoregulatory. Its likely immuno-regulatory mode of action is by mimicry of the thymic hormone thymopoietin. Chemically, levamisole may form a thymopoietin-mimetic tertiary structure, stimulate lymphocytes by its imidazole component, or be metabolized to O.M.P.I., a reducing compound which affects radical scavenging in multiplying lymphocytes. Physiologically, thymopoietin affects many components of the immune system including both neutrophils, macrophages, and lymphocytes and its therapeutically important actions are probably targeted at stimulation of phagocytosis and stimulation of regulatory T cells to restore homeostasis in a perturbed immune system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 310464

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  8 in total

1.  The immune response and the connective tissue diseases.

Authors:  M B Urowitz; R Buchanan
Journal:  Can Fam Physician       Date:  1979-03       Impact factor: 3.275

2.  An overview of the current status of levamisole in the treatment of rheumatic diseases.

Authors:  E C Huskisson; J G Adams
Journal:  Drugs       Date:  1980-08       Impact factor: 9.546

3.  HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis.

Authors:  Chin-Hsiu Liu; Sengupta Raj; Chun-Hsiung Chen; Kuo-Hsuan Hung; Chung-Tei Chou; Ing-Ho Chen; Jui-Teng Chien; I-Ying Lin; Shii-Yi Yang; Takashi Angata; Wen-Chan Tsai; James Cheng-Chung Wei; I-Shiang Tzeng; Shih-Chieh Hung; Kuo-I Lin
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

4.  The growth and spontaneous dissemination of melanoma B16 and Lewis lung tumour in two sub-strains of C57BL/6J mice treated with Corynebacterium parvum and/or levamisole.

Authors:  B Boeryd; A Benktson
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

5.  Intestinal Parasitoses in HIV Infected Children in a Nigerian Tertiary Hospital.

Authors:  Olusola Adetunji Oyedeji; Ebun Adejuyigbe; Samuel Olorunyomi Oninla; Abiodum Akeem Akindele; Samuel Adeyinka Adedokun; Efeturi Agelebe
Journal:  J Clin Diagn Res       Date:  2015-11-01

6.  Comparative efficacy of ivermectin and levamisole for reduction of migrating and encapsulated larvae of Baylisascaris transfuga in mice.

Authors:  Yan Fu; Hua-Ming Nie; Li-Li Niu; Yue Xie; Jia-Bo Deng; Qiang Wang; Guang-You Yang; Xiao-Bin Gu; Shu-Xian Wang
Journal:  Korean J Parasitol       Date:  2011-06-14       Impact factor: 1.341

Review 7.  Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.

Authors:  Rebecca L Charlton; Bartira Rossi-Bergmann; Paul W Denny; Patrick G Steel
Journal:  Parasitology       Date:  2017-08-14       Impact factor: 3.234

Review 8.  Unconventional Treatments for Vitiligo: Are They (Un) Satisfactory?

Authors:  Serena Gianfaldoni; Georgi Tchernev; Jacopo Lotti; Uwe Wollina; Francesca Satolli; Miriam Rovesti; Katlein França; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.